Search Results

Results for "T"

Model Innovation in Parkinson’s Disease Drug Development: Linking Quantitative Systems Pharmacology to the Patient Voice – Jeff Barrett, et al. Abstract # 287

The Development of a Parkinson’s Disease Biomarker Inventory Dashboard – Michael Pauley, et al. Abstract # 308

Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium – Martijn Müller, et al. Abstract # 341

Identifying and Controlling Variability in Digital Health Measures in Parkinson’s Disease Clinical Trials – George Roussos, et al. Abstract # 342

Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease – Derek Hill, et al. Abstract # 1289

A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s Disease leveraging the voice of the patient – Sakshi Sardar, et al. Abstract # 1314

Academic Innovation Leader and Experienced Scientist to Join C-Path’s PKD Consortium

Sorin Fedeles, Ph.D., MBA to serve as new Executive Director TUCSON, Ariz., October 14, 2021 – Critical Path Institute (C-Path)

C-Path’s Quantitative Medicine Team to Lead Trainee Tutorial at American Conference on Pharmacometrics

On November 12, 2021 Jagdeep Podichetty, Director of Predictive Analytics within Quantitative Medicine program at Critical Path In

C-Path Joins New Coalition to Improve Patient Care and Address Unmet Medical Needs through Community-Level Clinical Trials

Tools being developed by C-Path’s CURE Drug Repurposing Collaboratory will help incorporate adaptive platform trial protocol

C-Path and Cure Mito Announce Data Sharing Agreement to Support Treatment Development For Leigh Syndrome and Mitochondrial Disease

TUCSON, Ariz., November 9, 2021 — Critical Path Institute (C-Path) and Cure Mito Foundation (Cure Mito) today announced a joint

Previous89 10...132 Next